213 related articles for article (PubMed ID: 33762526)
21. Risk of Ischemic Stroke in Patients With Non-Valvular Atrial Fibrillation Not Receiving Oral Anticoagulants - Korean Nationwide Population-Based Study.
Kang SH; Choi EK; Han KD; Lee SR; Lim WH; Cha MJ; Cho Y; Oh IY; Oh S
Circ J; 2017 Jul; 81(8):1158-1164. PubMed ID: 28413184
[TBL] [Abstract][Full Text] [Related]
22. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
[TBL] [Abstract][Full Text] [Related]
23. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
24. Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
Tanaka K; Koga M; Lee KJ; Kim BJ; Park EL; Lee J; Mizoguchi T; Yoshimura S; Cha JK; Lee BC; Nakahara J; Suzuki N; Bae HJ; Toyoda K;
Stroke; 2020 Apr; 51(4):1150-1157. PubMed ID: 32098607
[TBL] [Abstract][Full Text] [Related]
25. Significance of CHA
Cheng X; Liu L; Li L; Zhao H; Li J; Shi J; Zhang W
Intern Emerg Med; 2021 Aug; 16(5):1155-1163. PubMed ID: 33386603
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.
Iso K; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Hayashi H; Iwasaki YK; Shimizu W; Nakajima I; Harada T; Koyama J; Okumura K; Tokuda M; Yamane T; Tanimoto K; Momiyama Y; Nonoguchi N; Soejima K; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Yazaki Y; Satomi K; Watari Y; Okumura Y;
Heart Vessels; 2021 Apr; 36(4):549-560. PubMed ID: 33236221
[TBL] [Abstract][Full Text] [Related]
27. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.
Wang JR; Du X; Dong JZ; Chang SS; Jiang C; Sang CH; Long DY; Tang RB; Zhang HB; Guo JC; Wen YM; He L; Ma CS
Clin Cardiol; 2022 Jan; 45(1):60-67. PubMed ID: 34952974
[TBL] [Abstract][Full Text] [Related]
28. Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
Senoo K; Lane DA; Lip GY
Int J Cardiol; 2015 Feb; 181():247-54. PubMed ID: 25528530
[TBL] [Abstract][Full Text] [Related]
29. Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry.
Tomita H; Okumura K; Inoue H; Atarashi H; Yamashita T; Origasa H; Tsushima E;
Circ J; 2015; 79(8):1719-26. PubMed ID: 25971525
[TBL] [Abstract][Full Text] [Related]
30. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG
Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828
[TBL] [Abstract][Full Text] [Related]
31. CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation.
Wei-Syun Hu ; Lin CL
Lupus; 2018 Jul; 27(8):1240-1246. PubMed ID: 29554836
[TBL] [Abstract][Full Text] [Related]
32. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
33. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
[TBL] [Abstract][Full Text] [Related]
34. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
35. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
[TBL] [Abstract][Full Text] [Related]
36. Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.
Mizokami Y; Yamamoto T; Atarashi H; Yamashita T; Akao M; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
PLoS One; 2020; 15(11):e0240859. PubMed ID: 33151969
[TBL] [Abstract][Full Text] [Related]
37. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
38. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
39. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
40. Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF.
Kodani E; Tomita H; Nakai M; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y; Okumura K;
Eur Heart J Open; 2022 Nov; 2(6):oeac081. PubMed ID: 36583077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
